Gadiyaram Srikanth, Nachiappan Murugappan
Department of Surgical Gastroenterology and MIS, Sahasra Hospital, Bengaluru, Karnataka, India.
J Minim Access Surg. 2022 Oct-Dec;18(4):596-602. doi: 10.4103/jmas.jmas_314_21.
Subtotal cholecystectomy has been reported in 8% and 3.3% of patients undergoing open and laparoscopic cholecystectomy, respectively. According to a recent nationwide survey, the utilisation of subtotal cholecystectomy in the treatment of acute cholecystitis is on the rise. In 1.8% of subtotal cholecystectomies, a reoperation is required. Reoperations for residual gallbladder (GB), gallstones, and related complications accounted for half of the reoperations described in the literature after subtotal cholecystectomy. The purpose of this study was to evaluate the clinical profile, risk of complications, and feasibility of laparoscopic approaches and surgical procedures in patients with recurrent symptoms from a residual GB that necessitated a completion cholecystectomy.
Patients who underwent surgery for residual GB with stones and/or complications between January 2007 and January 2020 were included in the study group. A prospectively maintained database was used to review patient information retrospectively. The demographic profile, operation details of the index surgery, current presentation, investigations performed, surgery details, morbidity and mortality were all included in the clinical information.
There were 13 patients who underwent completion cholecystectomy. The median age was 55 years (22-63 years). Prior operative notes mentioned subtotal cholecystectomy in only seven patients. The average time between the index surgery and the onset of symptoms was 30 months (2-175 months). A final diagnosis of residual GB with or without calculi was made by ultrasound (USG) in 11 patients and by magnetic resonance cholangiopancreatography (MRCP) in two others. Choledocholithiasis (n = 4, 30.7%), acute cholecystitis (n = 2, one with empyema and GB perforation) and Mirizzi syndrome (n = 1) were seen as complications of residual gallstones in seven patients. All 13 patients underwent successful laparoscopic procedures. A fifth port was used in all. A critical view of safety was achieved in 12 patients. Two patients required laparoscopic common bile duct (CBD) exploration for CBD stones. Intraoperative cholangiograms were done in eight patients (61.5%). There were no conversions, injuries to the bile duct or deaths. Morbidity was seen in one. The patient required therapeutic endoscopic retrograde cholangiography for cholangitis and CBD clearance on the fifth post-operative day. The median hospital stay was 4 days (3-7 days). At a median follow-up of 99 months, symptom resolution was seen in all 13 patients.
Gallstones in the residual GB are associated with more complications than conventional gallstones. The diagnosis requires a high level of suspicion. MRCP is more accurate in establishing the diagnosis and identifying the associated complications, even if the diagnosis is made on USG in most patients. A pre-operative roadmap is provided by the MRCP. For patients with residual GB, laparoscopic completion cholecystectomy is a feasible and safe option.
据报道,分别有8%和3.3%的接受开腹胆囊切除术和腹腔镜胆囊切除术的患者进行了次全胆囊切除术。根据最近一项全国性调查,次全胆囊切除术在急性胆囊炎治疗中的应用正在增加。在1.8%的次全胆囊切除术中,需要再次手术。文献中描述的次全胆囊切除术后再次手术的病例中,因残留胆囊(GB)、胆结石及相关并发症进行的再次手术占一半。本研究的目的是评估因残留GB出现复发症状而需要完成胆囊切除术的患者的临床特征、并发症风险以及腹腔镜手术方法和手术操作的可行性。
研究组纳入2007年1月至2020年1月期间因残留GB伴结石和/或并发症而接受手术的患者。使用前瞻性维护的数据库对患者信息进行回顾性分析。临床信息包括人口统计学特征、首次手术的手术细节、当前临床表现、所做检查、手术细节、发病率和死亡率。
13例患者接受了完成胆囊切除术。中位年龄为55岁(22 - 63岁)。之前的手术记录仅提及7例患者进行了次全胆囊切除术。首次手术与症状出现之间的平均时间为30个月(2 - 175个月)。11例患者通过超声(USG)最终诊断为残留GB伴或不伴结石,另外2例通过磁共振胰胆管造影(MRCP)确诊。7例患者出现残留胆结石的并发症,包括胆总管结石(n = 4,30.7%)、急性胆囊炎(n = 2,其中1例伴有积脓和GB穿孔)和Mirizzi综合征(n = 1)。所有13例患者均成功接受了腹腔镜手术。均使用了第五个端口。12例患者实现了安全的视野。2例患者因胆总管(CBD)结石需要进行腹腔镜胆总管探查。8例患者(61.5%)进行了术中胆管造影。无中转开腹、胆管损伤或死亡病例。1例出现并发症。该患者在术后第5天因胆管炎需要进行治疗性内镜逆行胆管造影及胆总管清理。中位住院时间为4天(3 - 7天)。中位随访99个月时,13例患者症状均缓解。
残留GB中的胆结石比传统胆结石伴有更多并发症。诊断需要高度怀疑。即使大多数患者通过USG确诊,MRCP在明确诊断和识别相关并发症方面更准确。MRCP提供了术前路线图。对于残留GB的患者,腹腔镜完成胆囊切除术是一种可行且安全的选择。